SOURCE: Applied Spectrum Technologies, Inc.

February 09, 2007 16:34 ET

Applied Spectrum Technologies, Inc. Announces Name Change and New Ticker Symbol

HUBEI PROVINCE, CHINA -- (MARKET WIRE) -- February 9, 2007 -- Applied Spectrum Technologies, Inc. (OTCBB: APSP), a China-based pharmaceutical company engaged in the development, manufacturing and distribution of medicines, active pharmaceutical ingredients and pharmaceutical intermediaries, announced today that pursuant to a Certificate of Amendment to the Company's Certificate of Incorporation, as filed with the Delaware Secretary of State on January 29, 2007, the name of the Company has been changed to Benda Pharmaceutical, Inc. (hereafter "Benda" or the "Company").

The Company also announced that effective February 12, 2007, its ticker symbol on the Over-The-Counter Bulletin Board ("OTC BB") will be changed to "BPMA."

About Benda Pharmaceutical, Inc.

Benda Pharmaceutical, Inc. ( is engaged in the business of identifying, discovering, developing, and manufacturing conventional medicines, active pharmaceutical ingredients, bulk chemicals (or pharmaceutical intermediates), and Traditional Chinese Medicines ("TCMs") for the treatment of some of the most widespread common ailments and diseases (e.g. common cold, diabetes, and cancer).


The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact Information